for our newsletter!
MC-Val-Cit-PAB-MMAF is a drug-linker conjugate for ADC with antitumor activity by using the tubulin inhibitor, MMAF, linked via cathepsin cleavable MC-Val-Cit-PAB. Potential mode of action/Key words: Targeting Tubulin, Tubulin inhibitor, Antitumoral, Targeting Tubulin
Toxins with Linkers
Cfm Oskar Tropitzsch GmbH also provides linker-drug conjugates. Either as linker-drug conjugate or under contract synthesis arrangements. To take advantage of this service please contact us firstname.lastname@example.org for more information. Some ...